Categories Earnings Calls, Health Care

Pfizer Inc. (PFE) Q4 2020 Earnings Call

Pfizer Inc. (NYSE: PFE) Q4 2020 earnings call dated Feb. 02, 2021

Corporate Participants:

Charles E. Triano — Senior Vice President, Investor Relations

Albert Bourla — Chairman and Chief Executive Officer

Mikael Dolsten — Chief Scientific Officer and President, Worldwide Research, Development and Medical

Angela Hwang — Group President, Pfizer Biopharmaceuticals Group

Frank D’Amelio — Chief Financial Officer and Executive Vice President, Global Supply

John Young — Group President, Chief Business Officer

Analysts:

David Risinger — Morgan Stanley — Analyst

Steve Scala — Cowen — Analyst

Gregg Gilbert — Truist Securities — Analyst

Louise Chen — Cantor Fitzgerald — Analyst

Umer Raffat — Evercore — Analyst

Geoffrey Porges — SVB Leerink — Analyst

Vamil Divan — Mizuho — Analyst

Tim Anderson — Wolfe Research — Analyst

Jason Zemansky — Bank of America — Analyst

Ronny Gal — Bernstein — Analyst

Navin Jacob — UBS — Analyst

Chris Schott — JPMorgan — Analyst

_________
To read the full earnings call transcript, click here

Most Popular

CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%

Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss

Key metrics from Nike’s (NKE) Q2 2025 earnings results

NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net

FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips

Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top